You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Operable

Showing 1 - 25 of 975
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Cancer, Depression, Anxiety Trial in Salt Lake City (Ketamine)

Not yet recruiting
  • Gastrointestinal Cancer
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 14, 2023

NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Yangzhou, Jiangsu, China
    People's hospital of northern jiangsu
Sep 26, 2023

Trajectories of Fatigue and Quality of Life in People With Both

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Diabetes Mellitus
    • (no location specified)
    Aug 22, 2023

    Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • 3cycles (Toripalimab + cetuximab)
    • +2 more
    • Wuhan, Hebei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 6, 2023

    TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • (no location specified)
    May 8, 2023

    NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

    Recruiting
    • NSCLC
    • SBRT+LDRT
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 2, 2023

    Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

    Not yet recruiting
    • Metastatic Malignancy
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 19, 2022

    Breast Cancer Trial in Bronx (TMEM-MRI, FNA)

    Recruiting
    • Breast Cancer
    • TMEM-MRI
    • FNA
    • Bronx, New York
      Montefiore Medical Center
    Jan 30, 2023

    Sarcoma Trial in Helsinki (Imatinib)

    Recruiting
    • Sarcoma
    • Helsinki, Finland
      Helsinki University Central Hospital
    Sep 26, 2022

    Breast Cancer,Her2 Positive Trial in Zhengzhou (Albumin binding paclitaxel+ trastuzumab+ patuzumab, Docetaxel+ carboplatin+

    Recruiting
    • Breast Cancer,Her2 Positive
    • Albumin binding paclitaxel+ trastuzumab+ patuzumab
    • Docetaxel+ carboplatin+ trastuzumab + patuzumab
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 19, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Tucson, Arizona
    • +1 more
    Sep 22, 2022

    HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)

    Recruiting
    • HER2-positive Breast Cancer
    • Operable Breast Cancer
    • Avignon, France
    • +8 more
    Jan 9, 2023

    PREDICT Version 2.2 of Indian Women With Operable Breast Cancer

    Active, not recruiting
    • Operable Breast Neoplasms
    • prediction of overall survival using Web based PREDICTV2.0 portal
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Apr 28, 2022

    HER2 Negative Breast Cancer Not Immediately Operated Trial (Ribociclib Oral Tablet)

    Not yet recruiting
    • HER2 Negative Breast Cancer Not Immediately Operated
    • Ribociclib Oral Tablet
    • (no location specified)
    Dec 16, 2022

    Colon Cancer Stage I, Colon Cancer Stage II Trial in Sohag (laparoscopic conventional colectomy, laparoscopic complete mesocolic

    Recruiting
    • Colon Cancer Stage I
    • Colon Cancer Stage II
    • laparoscopic conventional colectomy
    • laparoscopic complete mesocolic excision
    • Sohag, Egypt
      Sohag faculty of medicine
    Jun 28, 2022

    Neoadjuvant Chemotherapy on Peripheral Blood Immune Phenotype in

    Recruiting
    • Invasive Breast Carcinoma
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 16, 2022

    Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Locally Advanced Operable
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 4, 2023

    Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • New York, New York
      Columbia University Medical Center - Herbert Irving Cancer Cente
    Aug 16, 2022

    Hepatocellular Carcinoma Non-resectable Trial (Selective Internal Radiation Therapy with 188Re-SSS lipiodol)

    Not yet recruiting
    • Hepatocellular Carcinoma Non-resectable
    • Selective Internal Radiation Therapy with 188Re-SSS lipiodol
    • (no location specified)
    Mar 22, 2023

    Bladder Cancer, Quality of Life Trial in Taipei (Usual care + oncology case manager (OCM) care, Multi-domains Active-living

    Recruiting
    • Bladder Cancer
    • Quality of Life
    • Usual care + oncology case manager (OCM) care
    • Multi-domains Active-living Program (MAP) with e-health enhanced intervention + usual care + oncology case manager (OCM) care
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 13, 2023

    NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

    Active, not recruiting
    • NSCLC Stage II
    • NSCLC, Stage IIIA
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    NSCLC Trial in Changsha (envafolimab)

    Enrolling by invitation
    • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      the second Xiangya hospital
    May 1, 2022

    Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

    Recruiting
    • Carcinoma Breast Stage I
    • HER2 Positive Breast Cancer
    • Mumbai, India
      Tata Memorial Centre
    Apr 26, 2022

    Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Birmingham, Alabama
    • +4 more
    Feb 1, 2023

    Chemo-Related Cognitive Impairment, Breast Cancer Trial in Guangzhou (Ganglioside-Monosialic Acid, 250ml normal saline (NS))

    Recruiting
    • Chemotherapy-Related Cognitive Impairment
    • Breast Cancer
    • Ganglioside-Monosialic Acid
    • 250ml normal saline (NS)
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 25, 2022